Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Sulfonylurea (substance) |
Is a |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Product containing metformin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Product containing biguanide (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Product containing troglitazone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Product containing thiazolidinedione (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Oral hypoglycemic identification |
Component |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Poisoning caused by metformin (disorder) |
Causative agent (attribute) |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Oral hypoglycemic poisoning |
Causative agent (attribute) |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Accidental poisoning by metformin |
Causative agent (attribute) |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Intentional poisoning by metformin |
Causative agent (attribute) |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Poisoning caused by metformin of undetermined intent |
Causative agent (attribute) |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Accidental phenformin poisoning |
Causative agent (attribute) |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Intentional phenformin poisoning |
Causative agent (attribute) |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Phenformin poisoning of undetermined intent |
Causative agent (attribute) |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Oral hypoglycemic allergy |
Causative agent (attribute) |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Allergy to biguanide (finding) |
Causative agent (attribute) |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Allergy to metformin (finding) |
Causative agent (attribute) |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Allergy to acarbose |
Causative agent (attribute) |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Oral hypoglycemic overdose |
Causative agent (attribute) |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Biguanide overdose |
Causative agent (attribute) |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Overdose of metformin |
Causative agent (attribute) |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Accidental overdose by metformin |
Causative agent (attribute) |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Intentional overdose by metformin |
Causative agent (attribute) |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
surdose de metformine d'intention indéterminée |
Causative agent (attribute) |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Product containing metformin hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Metformin hydrochloride 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Metformin hydrochloride 850 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Troglitazone 200 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Troglitazone 300 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Troglitazone 400 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Product containing rosiglitazone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Rosiglitazone (as rosiglitazone maleate) 8 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Product containing precisely rosiglitazone (as rosiglitazone maleate) 4 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Product containing pioglitazone (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Pioglitazone (as pioglitazone hydrochloride) 30 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 15 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Oral hypoglycemic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Poisoning caused by oral biguanide derivative |
Causative agent (attribute) |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Rosiglitazone maleate 2mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Product containing precisely pioglitazone (as pioglitazone hydrochloride) 45 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Metformin hydrochloride 1 g oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Metformin hydrochloride 500mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Rosiglitazone maleate |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Guar gum (substance) |
Is a |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Poisoning by phenformin |
Causative agent (attribute) |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Biguanide (substance) |
Is a |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Combination oral hypoglycemic |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Pioglitazone hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Alpha-glucoside inhibitor |
Is a |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
agent hypoglycémiant oral de type biguanide |
Is a |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Product containing biguanide (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Oral hypoglycemic adverse reaction |
Causative agent (attribute) |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Biguanide overdose |
Causative agent (attribute) |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Poisoning caused by oral biguanide derivative |
Causative agent (attribute) |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Adverse reaction to insulins and antidiabetic agents NOS |
Causative agent (attribute) |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Product containing precisely rosiglitazone maleate 2 milligram/1 each conventional release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Sitagliptin (substance) |
Is a |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Miglitol |
Is a |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Acarbose (substance) |
Is a |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Vildagliptin (substance) |
Is a |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Poisoning caused by oral sulfonylurea derivative |
Causative agent (attribute) |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Oral hypoglycemic allergy |
Causative agent (attribute) |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
1 |
Linagliptin (substance) |
Is a |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Alogliptin |
Is a |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Saxagliptin (substance) |
Is a |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|
Allergy to guar gum (finding) |
Causative agent (attribute) |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
2 |
Guar gum adverse reaction |
Causative agent (attribute) |
False |
Oral hypoglycemic |
Inferred relationship |
Some |
|